GWPH News and Press, GW Pharmaceuticals Plc From 01/11/21

The newly constituted Senate gives a green light for cannabis. Vice-President elect Kamala Harris sponsored the More Act in the Senate. Removing cannabis entirely as a scheduled substance from the Controlled Substances Act is a financial godsend to cannabis companies. Get read...

GW Pharmaceuticals ([[GWPH]] +2.6%) expects Q4 net product sales to be ~$148M vs. consensus of $141.16M and ~$526M for FY2020 vs. consensus of $520.99M.Total Epidiolex net product sales expected to be ~$144M for the quarter comprising of $129M in the US and $15M ex-US.  and ~$5...

Ahead of the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, GW Pharmaceuticals plc (Nasdaq: GWPH)released preliminary, unaudited net product sales for the fourth quarter and full-year 2020 and key priorities for 2021. GW Pharma said it expects total net product ...

- Total preliminary net product sales of approximately $148 million for the fourth quarter and approximately $526 million for the full year - - Total Epidiolex ® preliminary net product sales of approximately $144 million for the fourth quarter and approximately $51...

Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...

FinancialBuzz.com News Commentary New York, NY (1/6/2021) – The cannabis industry has had some major accomplishments in recent years. 16 states have now fully legalized the use of cannabis products for both medical and recreational use. Furthermore, in last year’s election...

LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group) under the same headline, please note the time of the conference and breakout session have changed. The conference will...

LONDON and CARLSBAD, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that Justin Gover, GW’s Chief...

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...